XML 37 R26.htm IDEA: XBRL DOCUMENT v3.6.0.2
Intangible Assets - Additional Information (Detail) - USD ($)
3 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Finite Lived Intangible Assets [Line Items]    
Amortization expense $ 425,107 $ 438,991
Amortization of license agreements remainder of fiscal year 2017 1,275,322  
Amortization of license agreements in 2018 1,700,429  
Amortization of license agreements in 2019 1,700,429  
Amortization of license agreements in 2020 1,700,429  
Amortization of license agreements in 2021 1,700,429  
Amortization of license agreements in 2022 1,700,429  
Amortization of license agreements, thereafter $ 11,962,294  
Novartis | Licensing Agreements    
Finite Lived Intangible Assets [Line Items]    
Amortization period of intangible assets 21 years  
Finite-lived intangible assets, accumulated amortization $ 272,076  
Novartis | Patents    
Finite Lived Intangible Assets [Line Items]    
Amortization period of intangible assets 14 years  
Finite-lived intangible assets, accumulated amortization $ 2,845,377